Capri Holdings beats Q4 adjusted profit estimates estimates
Capri Holdings beats Q4 adjusted profit estimates estimates
Overview
US luxury fashion group's fiscal Q4 revenue fell 3.7%, slightly missing analyst expectations
Adjusted net income and EPS beat analyst expectations
Company repurchased $79 mln in shares during the quarter
Outlook
Capri Holdings expects FY 2027 revenue of about $3.525 bln and EPS of $2.15
Company sees fiscal 2027 Michael Kors revenue at $2.9 bln, Jimmy Choo at $625 mln
Capri Holdings projects Q1 2027 revenue of about $750 mln and EPS of $0.40
Result Drivers
TARIFF REFUND - Q4 gross margin benefited from a $40 mln reduction in cost of goods sold due to an expected refund of previously paid IEEPA tariffs
STRATEGIC INITIATIVES - Co said actions to strengthen product innovation, brand desirability and consumer engagement are gaining traction, per CEO John D. Idol
Company press release: ID:nBw5VRlw8a
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue | Slight Miss* | $796 mln | $796.38 mln (14 Analysts) |
Q4 Adjusted EPS | Beat | $0.22 | $0.11 (14 Analysts) |
Q4 EPS |
| -$0.01 |
|
Q4 Adjusted Net Income | Beat | $27 mln | $13.50 mln (13 Analysts) |
Q4 Net Income |
| -$3 mln |
|
Q4 Adjusted Operating Income | Beat | -$1 mln | -$17.46 mln (14 Analysts) |
Q4 Operating Income |
| -$27 mln |
|
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Capri Holdings
See all newsU.S. STOCKS ON THE MOVE-Boston Scientific, Banc of California, Salesforce
U.S. STOCKS ON THE MOVE-UnitedHealth, Astrotech, Boston Scientific
Capri Holdings Ltd reports results for the quarter ended March 31 - Earnings Summary
U.S. STOCKS ON THE MOVEd-Micron, Abercrombie & Fitch, Q32 Bio
U.S. STOCKS ON THE MOVE-MGM, Hims & Hers, Semtech